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Available online 7 July 2016Forskolin (FSK) induces activation of protein kinase A (PKA). This activation protects speciﬁcally some cancer
cells from death induced by glucose starvation. Cell effects upon FSK treatment prompted us to investigate in de-
tail the physiological role of PKA in the activation of pro-survivalmechanisms in glucose starvation. In this regard
we performed a microarray analysis of normal NIH3T3 and transformed NIH3T3-K-ras mouse ﬁbroblasts cul-
tured at 1mMglucose and daily treated or not with 10 μMFSK until 72 h of growth, when the sampleswere col-
lected. The microarray is deposited into Gene Expression Omnibus under Series GSE68266. The microarray data
revealed that the activation of PKA regulates the expression of genes involved in metabolic, stress-response and
pro-survival processes, like glutaminemetabolism, autophagy and unfolded protein response, preventing cancer
cell death in glucose starvation. Altogether these ﬁndings suggest that PKA activation, by inducing a complex
transcriptional program, leads to cancer survival in nutrient stress, a typical feature of developing tumor. These
transcriptional data, identifying this important role of PKA, will be useful to identify novel target in cancer
therapy.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Where applicable, please follow the Ontology for Biomedical Investi-
gations: http://obi-ontology.org/page/Main_Pagerganism/cell
line/tissueNIH3T3 mouse ﬁbroblasts and transformed NIH3T3-K-rasx NA
quencer or
array typeMouse Genechip MoGene-1_0 -st-v1 Arrays (Affymetrix)ata format Raw data: CEL ﬁles, normalized data: SOFT, MINIML, TXT
xperimental
factorsImmortalized NIH3T3 mouse ﬁbroblasts vs. transformed
NIH3T3-K-ras mouse ﬁbroblasts cultured at 1 mM glucose and
daily treated with 10 μM Forskolinxperimental
featuresTranscriptome proﬁling of genes modulated by PKA in
immortalized and transformed mouse ﬁbroblasts. Cells were
cultured in medium with 1 mM glucose and then treated with
FSK. The samples for the microarray analysis were collected at
72 h of culture in low glucose after daily treatments with FSK.onsent Data are publicly availableCF. Chiaradonna),
pus.unimib.it (F. Ricciardiello),
. This is an open access article under1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE682662. Experimental design, materials and methods
2.1. Cell culture and reagents
The immortalized NIH3T3 and the transformed NIH3T3-K-ras cell
lines were routinely maintained in DMEMmedium (Life Technologies)
with 10% new born calf serum (Life Technologies), 25 mM glucose and
other supplements as described previously [1,2]. All cells were cultured
at 37 °C in 5% CO2. To perform the array experiments the cells were
seeded at 3000 cells/cm2 in complete growth medium. After 16 h, the
cells were washed twice with phosphate-buffered saline and incubated
in medium (time 0) supplemented with 1 mM glucose instead of
25mM(Fig. 1). To induce the increase of cAMP levels and hence PKA ac-
tivation, the cells were daily treatedwith 10 μM forskolin (FSK) (Sigma-
Aldrich) starting from 24 h after medium replacement. FSK-treated and
untreated (DMSO) cells were then collected for array analyses at 72 h of
culture in low glucosemedium,which corresponds to 48 h of FSK-treat-
ment (Fig. 1). The basal and the FSK-induced cAMP levels as well as the
PKA activation in both cell lines are described in [1,2].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Experimental scheme.
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Cells were lysed in TRIZOL (Invitrogen, Carlsbad, CA) and total RNA
was further puriﬁed with the Rneasy kit (QIAGEN, Hilden, Germany)
following manufacturer instructions. RNA was quantiﬁed on the
NanoDrop ND-1000. RNA quality and integrity was determined by an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) on
RNA Nano Chips. RNA integrity numbers (RIN) were N8.5 indicating
high RNA quality. Single strand biotinylated cDNAwas generated as fol-
lows: 100 ng of total RNA were subjected to 2 cycles of cDNA synthesis
with the AmbionWT expression Kit (Life Technologies). The ﬁrst cycle -
ﬁrst strand synthesis is performed using an engineered set of random
primers that exclude rRNA-matching sequences and include the T7 pro-
moter sequences. After second-strand synthesis, the resulting cDNA is in
vitro transcribed with the T7 RNA polymerase to generate a cRNA. This
cRNA is subjected to a second cycle - ﬁrst strand synthesis in the pres-
ence of dUTP in a ﬁxed ratio relative to dTTP. Single strand cDNA is
then puriﬁed and fragmented with a mixture of uracil DNA glycosylase
and apurinic/apirimidinic endonuclease 1 (Affymetrix) in correspon-
dence of incorporated dUTPs. DNA fragments are then terminally la-
beled by terminal deoxynucleotidyl transferase (Affymetrix) with
biotin. The biotinylated DNA was hybridized to the Mouse Genechip
MoGene-1_0 -st-v1 Arrays (Affymetrix), containing almost 23000
genes selected fromMus musculus genome databases RefSeq, ENSEMBLTable 1
Sample identity.
Samples Parameter
Phenotype
NIH3T3 Normal
NIH3T3 Normal
NIH3T3 Normal
NIH3T3-K-ras Transformed
NIH3T3-K-ras Transformed
NIH3T3-K-ras Transformed
NIH3T3 Normal
NIH3T3 Normal
NIH3T3 Normal
NIH3T3-K-ras Transformed
NIH3T3-K-ras Transformed
NIH3T3-K-ras Transformedand GenBank. Chips were washed and scanned on the Affymetrix Com-
plete GeneChip Instrument System, generating digitized image data
(DAT) ﬁles. Data where then normalized using a Global Normalization
approach with the Affymetrix Gene Expression Console software, gen-
erating the .CEL ﬁles
2.3. Microarray and gene expression analysis
Microarray analysis was performed on biological triplicate samples.
Labeling of cDNA and hybridization to Mouse MoGene-1_0 -st-v1 Ar-
rays were performed at the IRGS, Biogem, Ariano Irpino (AV), Italy.
The samples included (see Table 1): 1) GSM1666885, immortalized
NIH3T3 mouse ﬁbroblasts replicate 1, 2) GSM1666886, immortalized
NIH3T3 mouse ﬁbroblasts replicate 2, 3) GSM1666887, immortalized
NIH3T3 mouse ﬁbroblasts replicate 3, 4) GSM1666888, NIH3T3-K-ras
transformed mouse ﬁbroblasts replicate 1, 5) GSM1666889, NIH3T3-
K-ras transformed mouse ﬁbroblasts replicate 2, 6) GSM1666890,
NIH3T3-K-ras transformed mouse ﬁbroblasts replicate 3, 7)
GSM1666891, immortalized NIH3T3 mouse ﬁbroblasts treated with
FSK replicate 1, and 8) GSM1666892, immortalized NIH3T3 mouse ﬁ-
broblasts treated with FSK replicate 2, 9) GSM1666893, immortalized
NIH3T3 mouse ﬁbroblasts treated with FSK replicate 3, 10)
GSM1666894, NIH3T3-K-ras transformed mouse ﬁbroblasts treated
with FSK replicate 1, 11) GSM1666895, NIH3T3-K-ras transformedGEO identiﬁcation number
Treatment (FSK)
− GSM1666885
− GSM1666886
− GSM1666887
− GSM1666888
− GSM1666889
− GSM1666890
+ GSM1666891
+ GSM1666892
+ GSM1666893
+ GSM1666894
+ GSM1666895
+ GSM1666896
Fig. 2. Correlation among p-value vectors obtained for each gene set analysis test (indicated by letters from a to i) and each directionality class (annotated by colors on top and left of each
plot) for contrast NF/N (left) and contrast TF/T (right).
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NIH3T3-K-ras transformedmouse ﬁbroblasts treatedwith FSK replicate
3. All sampleswere normalized through the RobustMulti-arrayAverage
(RMA)method [3] with background correction and quantile normaliza-
tion at core genes level as implemented by the R/Bioconductor package
“oligo”. Gene name annotations have been downloaded from ENSEMBL
using Biomart on Jan. 22, 2015. Probes not mapping to an Entrez gene
have been discarded. The resulting dataset was composed of 22,035
probes mapping to 17,665 unique genes.
Differential expression analysis was performed using a linear model
approach with least-square ﬁtting and False Discovery Rate correction
as provided by the R/Bioconductor package “limma” [4]. Two differen-
tial expression tests (contrasts) were performed: untreated normal
cells vs. FSK-treated normal cells - denoted as NF/N - and untreated
transformed cells vs. FSK-treated transformed cells - denoted as TF/T.
Only the probe of each gene having the minimum average p-value in
the two contrasts has been kept. There were 496 genes (probes) with
absolute log fold-change at least 1 for contrast NF/N and 208 genes for
contrast TF/T.
To gain a better understanding of the biological implications of these
expression proﬁles, we performed a comprehensive gene set analysis of
the differential expression results using the implementation provided
by the R/Bioconductor package “piano” [5]. The analysis used as gene
sets the 202 KEGG pathways classiﬁed as metabolic or signaling as
downloaded on Jan. 22, 2015. The pathways contain 6885 unique
genes of which 6010 are included in the analysis dataset (approx. 34%
of the genes).
Package “piano” provides the implementation of several gene set
analysis tests and of a consensusmethodology to summarize the results
obtained with the different tests. This approach should be less sensitive
to possible hidden biases of the single tests and allows, for example, the
integration of sources of gene expression data with other types of high
throughput data like proteomic data obtained by 2-DIGE [2]. The follow-
ing tests have been performed:
a) Mean
b) Median
c) Sum
d) Maxmeane) Gene set enrichment analysis (GSEA)
f) Parametric analysis of gene set enrichment (PAGE)
g) Reporter features
h) Wilcoxon rank-sum test
i) Tail strength.
Tests (a)–(f) used t-values computed in the differential expression
analysis while tests (g)–(i) used the corresponding p-values (and log
fold changes, for devising the directionality). Tests (f), (g), (h) comput-
ed gene set statistics signiﬁcance via the theoretical null distribution,
while the remaining ones via gene (re)sampling.
Each test may return distinct p-values for each gene set (i.e., path-
way) in the following directionality classes:
– Distinct-directional (up or down), indicated as Dist(up) and
Dist(down), which tests if the expression of the gene set as a
whole is regulated in a distinct direction (either up or down). By def-
inition, a gene set cannot be signiﬁcant in both classes as regulations
in opposite directions will cancel out the effect.
– Mixed-directional (up or down), indicated as Mix(up) and
Mix(down),which tests if a signiﬁcant subset of its genes are coordi-
nately up- or down-regulated. A gene set can be signiﬁcant in both
classes.
– Non-directional, indicated as NonDir, which tests if the expression of
the gene set as a whole is signiﬁcantly perturbed, discarding any in-
formation about directionality.
A total of 35 p-value vectors over the 45 possible combinations for
each contrast have been obtained since not all tests returned results
for all the directionality classes. The combined analysis of the p-values
obtained by each gene set in the various directionality classes provides
a clear picture of the (possible) regulation of that gene set.
Consistency of the results has been empirically veriﬁed by comput-
ing the pairwise correlation between the p-value vectors. Fig. 2 depicts
the correlation matrices of the p-value vectors of contrast NF/N on the
left and of contrast TF/T on the right. Directionality classes of the p-
value vectors are indicated by the annotation bars on the top and on
the left of the two plots, while letters refer to the different gene set
Fig. 3. Principal Component Analysis (PCA) of the p-value vectors obtained for each gene set analysis test (indicated by letters from a to i) and each directionality class (colors) for contrast
NF/N (left) and contrast TF/T (right). Top: the space resulting after PCA in itsﬁrst three dimensions (x- and y-axes and letter size). Bottom: theproportion of the variance explained by each
PCA dimension (only those N1% have been shown).
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vectors of the same directionality class (obtained with different tests)
have strong correlation (see, for example, the class Dist(dn)), p-value
vectors of similar classes have a non-negligible correlation (see, for ex-
ample, Mix(dn) and Dist(dn)) and p-value vectors of opposite classes
are inversely correlated (see, for example, Dist(dn) and Dist(up)). Fur-
ther conﬁrmation is provided by the dendograms depicted on the
sides, showing that tests of the same directionality class cluster togeth-
er. The only exception is test (i) “Tail strength” for the distinct down-Fig. 4. Aggregated ranks computed by the consensus methodology implemented by “piano” for
gene sets (listed on the left) in a particular directionality class (listed at the bottom).directional class on both contrasts. Despite that, the p-values of the
gene sets on these classes still appear to be in accordance (albeit less
correlated) with the rest of the results and represent only a small per-
turbation that the ﬁnal consensus analysis should easily accommodate.
Principal Component Analysis (PCA) of the same set of vectors pro-
vides a second empirical support to the consistency of the results com-
puted by the different tests. Fig. 3 depicts each p-value vector
(represented as the corresponding letter, see the list above) for contrast
NF/N (left) and contrast TF/T (right) in the space of its ﬁrst threecontrast NF/N (left) and TF/T (right). Each column represents the aggregated ranks of the
104 F. Chiaradonna et al. / Genomics Data 9 (2016) 100–104principal components (x- and y-axes and size). Ideally, each directional-
ity class (represented by colors) should cluster together in the resulting
space. Almost all the vectors clustered as expected.
The most evident outliers are those computed by test (i) for the dis-
tinct down-directional class, that are placed near the vectors of the
mixed down-directional class. This conﬁrms the observation made be-
fore for Fig. 2 and, again, this should not represent an issue for the con-
sensus analysis.
Consensus aggregation as implemented in the R/Bioconductor pack-
age “piano” computes the overall consensus rank by ﬁrst ranking each
gene set in each directionality class for each method according to the
predicted p-value. These ranks are then aggregated according to the
Borda rule (a single-winner election method). Fig. 4 depicts the aggre-
gated ranks obtained by the gene sets that ranked in the ﬁrst 5 positions
in at least one directionality class. Directionality classes are represented
as columns while numbers and colors represent the position of each
gene set (row) in the aggregated rank of that column for both contrast
NF/N (left block) and contrast TF/T (right block). In general, a pathway
can be considered signiﬁcantly regulated in a particular directionality
class if it ranks in the ﬁrst positions (albeit a general cut-off does not
exist). As expected, pathways ranking high (i.e., small numbers) in a di-
rectionality class (see, for example, “Ribosome biogenesis in Eukary-
otes”) are ranked low (large numbers) in the opposite directionality
class. Such a representation provides a clear and concise comparison
of the regulation of pathways in the two contrasts, highlighting com-
mon regulation of pathways in normal and transformed cells, like “Ribo-
some biogenesis in Eukaryotes”, down-regulated in both NF/N and TF/T,
and speciﬁc pathway regulations, different for the two cell lines, like the
up-regulation of pathway “Steroid biosynthesis” detected in TF/T but
not in NF/N.3. Conclusion
The microarray data and the “piano” computational approach here
presented, have allowed to the identiﬁcation of signiﬁcant pro-survival
processes, otherwise hidden, regulated by PKA in glucose deprivation
[2]. A part from our approach, these data could be further used touncover other mechanisms of cancer resistance mediated by PKA,
whose role in cancer progression has assumed great relevance in recent
years [6–8].
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